Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Celgene
This is a test.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Progressed on standard anticancer therapy or for whom no other approved conventional therapy exists and have histological or cytological confirmation of advanced unresectable solid tumors, advanced unresectable colorectal cancer, or squamous cell carcinoma of the head and neck, or CD20-positive non-Hodgkin's lymphoma, or diffuse large B cell lymphoma, or follicular lymphoma
Solid tumors must have at least one site of measurable disease as determined by RECIST v1.1
Eastern cooperative oncology group performance status of 0 or 1
You may not be if
High-grade lymphomas (Burkitt's or lymphoblastic)
Has cancer with symptomatic central nervous system (CNS) involvement
History of class III or IV congestive heart failure (CHF) or severe non-ischemic cardiomyopathy, unstable angina, myocardial infarction, or ventricular arrhythmia within the previous 6 months
Clareo Health | A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers
